A Step toward an Optimized Rifampin Dose Completed

Martin J Boeree^{1

2}, Andreas H Diacon^{3

4}, Rodney Dawson^{5

6}, Kim Narunsky^{5

6}, Jeannine du Bois⁴, Amour Venter³, Patrick P J Phillips⁷, Stephen H Gillespie⁸, Timothy D McHugh⁹, Michael Hoelscher^{10

11}, Norbert Heinrich^{10

11}, Sunita Rehal⁷, Dick van Soolingen^{1

12}, Jakko van Ingen¹, Cecile Magis-Escurra¹, David Burger¹, Georgette Plemper van Balen¹, Rob E Aarnoutse¹

Affiliations

¹ 1 Radboud University Medical Center Nijmegen, the Netherlands and.
² 2 University Centre for Chronic Diseases Dekkerswald Groesbeek, the Netherlands.
³ 3 Stellenbosch University Tygerberg, South Africa and.
⁴ 4 TASK Applied Sciences Cape Town, South Africa.
⁵ 5 University of Cape Town Cape Town, South Africa and.
⁶ 6 The Lung Institute Cape Town, South Africa.
⁷ 7 Medical Research Council Clinical Trials Unit at University College London London, United Kingdom.
⁸ 8 The Medical School University of St Andrews St Andrews Fife, United Kingdom.
⁹ 9 University College London London, United Kingdom.
¹⁰ 10 University of Munich Munich, Germany and.
¹¹ 11 German Centre for Infection Research Munich, Germany.
¹² 12 National Institute for Public Health and the Environment Bilthoven, the Netherlands.

Comment

Martin J Boeree et al. Am J Respir Crit Care Med. 2015.

. 2015 Aug 15;192(4):525-6.

doi: 10.1164/rccm.201506-1061LE.

¹ 1 Radboud University Medical Center Nijmegen, the Netherlands and.
² 2 University Centre for Chronic Diseases Dekkerswald Groesbeek, the Netherlands.
³ 3 Stellenbosch University Tygerberg, South Africa and.
⁴ 4 TASK Applied Sciences Cape Town, South Africa.
⁵ 5 University of Cape Town Cape Town, South Africa and.
⁶ 6 The Lung Institute Cape Town, South Africa.
⁷ 7 Medical Research Council Clinical Trials Unit at University College London London, United Kingdom.
⁸ 8 The Medical School University of St Andrews St Andrews Fife, United Kingdom.
⁹ 9 University College London London, United Kingdom.
¹⁰ 10 University of Munich Munich, Germany and.
¹¹ 11 German Centre for Infection Research Munich, Germany.
¹² 12 National Institute for Public Health and the Environment Bilthoven, the Netherlands.

No abstract available

Comment on

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, McHugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE; PanACEA Consortium. Boeree MJ, et al. Am J Respir Crit Care Med. 2015 May 1;191(9):1058-65. doi: 10.1164/rccm.201407-1264OC. Am J Respir Crit Care Med. 2015. PMID: 25654354 Clinical Trial.
Finishing what they started: when do researchers' responsibilities end?
Menzies D. Menzies D. Am J Respir Crit Care Med. 2015 May 1;191(9):977-8. doi: 10.1164/rccm.201502-0409ED. Am J Respir Crit Care Med. 2015. PMID: 25932762 No abstract available.